Pure Raw Supplies, LLC beneficially owns 12,000,000 Series B Preferred Shares of Nutra Pharma, representing 100% of the reported class. For investors, the disclosure identifies the holder and states that it has no present plans involving specified corporate actions, while the position was received as a gift without payment or borrowed funds.
Key Highlights
- The holder says it has no current plans related to the corporate actions covered by Schedule 13D.
- Pure Raw Supplies identifies pharmaceutical consulting as its principal business.
- Pure Raw Supplies, LLC owns 12,000,000 Series B preferred shares of Nutra Pharma.
Nutra Pharma Corp (OTC: NPHC) has a reported holder with 12,000,000 Series B preferred shares, representing 100% of the reported class. Pure Raw Supplies, LLC holds the position for Investment purposes, according to the ownership disclosure.
12M Series B Preferred Shares Held
The transaction involved no payment or borrowed funds, and the holder said it was not part of a purchase transaction. Elizabeth Deitsch signed for Pure Raw Supplies as president on September 1. The Florida Limited Liability company lists its principal Business as pharmaceutical consulting. Pure Raw Supplies also stated that no person other than the holder has the right to receive dividends or direct proceeds from a sale of those shares.
No Current Plans for Listed Corporate Actions
The holder reported no transactions beyond those described in that section. The disclosure therefore identifies an investment-purpose position without a present proposal for those specified actions.
FAQs
Q: Who owns Nutra Pharma’s Series B preferred shares?
A: Pure Raw Supplies, LLC owns 12,000,000 Series B preferred shares of Nutra Pharma. The reported position represents 100% of the identified Series B preferred share class.
Q: How did Pure Raw Supplies acquire the Nutra Pharma stake?
A: Pure Raw Supplies reported that the transaction involved no payment and no borrowed funds. The holder also stated that it was not part of a purchase transaction.
Q: What is the key detail from this filing?
A: Nutra Pharma Corp (OTC: NPHC) has a reported holder with 12,000,000 Series B preferred shares, representing 100% of the reported class. Pure Raw Supplies, LLC holds the position for investment purposes, according to the ownership disclosure.
Download Free Report – Explore 3 Stock Ideas & Industry Insights
Unlock 3 stock ideas and key industry insights in our free report. This information is general in nature and does not consider your personal objectives, financial situation, or needs. It is not financial advice.
All investments involve risk—consider independent advice before making any investment decisions.
View 3 Research Reports
Disclaimer:
Kalkine Equities LLC, with Delaware File Number 4697384, Foreign Qualification Registration in California File Number 202109211078, and Texas File Number 805521396, is authorized to provide general advice only. The information on https://kalkine.com/ does not take into account any of your investment objectives, financial situation or needs. You should consider the appropriateness of advice taking into account your own objectives, financial situation and needs and seek independent financial advice before making any financial decisions. The link to our Terms and Conditions and Privacy Policy has been provided for your reference. On the date of publishing the reports (mentioned on the website), employees and/or associates of Kalkine do not hold positions in any of the stocks covered on the website. These stocks can change any time and readers of the reports should not consider these stocks as advice or recommendations later.